Joseph S. Zakrzewski, Director at Cyteir Therapeutics, Inc. (CYT), bought 21,202 shares at $1.30 ($28K) on 2022-12-07, disclosed to the SEC on 2022-12-08.
Open-market purchase of $28k CYT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ANTX | SELL | 2024-01-19 | $1.9M | — | Filing → |
| CYT | BUY | 2022-05-16 | $1K | — | Filing → |
| CYT | BUY | 2022-05-12 | $188K | — | Filing → |